Clonal hematopoiesis with DNMT3A mutations is associated with multiple system atrophy

Seungmin Lee,Han-Joon Kim,Seoyeon Kim,Bora Jin,HoYoung Jeon,Kyung Ah Woo,Jung Hwan Shin,Chansub Lee,Choonghyun Sun,Hogune Im,Hongyul An,Young Il Koh,Su-Yeon Choi,Beomseok Jeon

DOI: https://doi.org/10.1016/j.parkreldis.2024.107145

Abstract:Background: Clonal hematopoiesis of indeterminate potential (CHIP) is associated with cardiovascular diseases and other disorders, possibly via inflammation. Recent research suggests a connection of CHIP with neurodegenerative disorders. Objective: We aimed to investigate the association between multiple system atrophy (MSA) and CHIP. Methods: We included 100 patients with MSA and 4457 controls. Targeted sequencing of peripheral blood DNA samples was performed, focusing on a panel of 25 genes commonly. Linked to chip: The prevalence of CHIP in patients with MSA was assessed against controls at variant allele frequency (VAF) thresholds of 1.5 % and 2.0 %. Results: DNMT3A mutation rates were significantly higher in patients with MSA, with a VAF of 1.5 %, which remained significant after adjusting for age and sex (adjusted odds ratio, 1.848; 95 % CI, 1.024-3.335; p = 0.0416). Conclusion: Our results suggest an association between DNMT3A mutations and MSA.